India's largest online pharmacy PharmEasy mulls $1 billion IPO: Report

The company, backed by TPG and Temasek Holdings Pte, is working with advisers on a potential offering

PharmEasy
Photo: Shutterstock
Baiju Kalesh | Bloomberg
1 min read Last Updated : Aug 12 2021 | 1:27 AM IST
API Holdings Pvt., owner of India’s largest online pharmacy PharmEasy, is considering a Mumbai initial public offering that could raise as much as $1 billion, according to people familiar with the matter.

The company, backed by TPG and Temasek Holdings Pte, is working with advisers on a potential offering that could take place by March 2022, the people said. The firm plans to file a draft prospectus before the end of October, said one of the people, who asked not to be identified as the information is private.

PharmEasy has so far delivered more than 15 million orders from medicine to diagnostic kits to health care products, serving over 5 million families, according to its website. Its delivery service covers more than 1,000 Indian cities. The company in June bought a majority stake in Thyrocare Technologies Ltd. for 45.5 billion rupees ($611 million).

API Holdings raised about $420 million in June funding round valuing the company at about $4.1 billion, one of the people said.

Deliberations are at an early stage, and details of the offering could still change, the people said. A representative for API Holdings declined to comment, citing a quiet period.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :PharmEasyinitial public offerings IPOsIPOs

Next Story